MedWatch

Analyst on new Bose hearing aid: "Won't disrupt Danish manufacturers"

US electronics company Bose's announced launch of a new, cheap self-tuning hearing aid won't cause sales to plummet for established hearing aid manufacturers, analysts believe. Demant welcomes the competition and WSA plans to test Bose's new solution to understanding its technology.

Photo: Bose / PR

On Tuesday, US electronics company Bose Corporations announced that it would launch a new low-cost hearing aid which can be purchased without passing by another audiologist or healthcare professional for tuning and programming

Since the FDA approval in fall 2018, there has been no information on what the Bose hearing aid looked like, what it could do and what it would cost.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs